- ISIN
- US7133171055
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- May 6, 2022
Highlights
- Market Cap
- $100.18M
- Enterprise Value
- $77.80M
- EPS (TTM)
- -$1.75
- Gross Profit (TTM)
- -$1.40M
- EBITDA (TTM)
- -$62.22M
- Year Range
- $1.01 - $7.80
- Target Price
- $7.00
- ROA (TTM)
- -49.40%
- ROE (TTM)
- -57.63%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PEPG Performance Chart
PepGen Ltd (PEPG) is down 77.7% since the beginning of the year. At $1 per share, PEPG is trading 81.4% below its 52-week high of $8.
Loading charts...
Returns By Period
PepGen Ltd (PEPG) has returned -77.73% so far this year and -5.23% over the past 12 months.
PepGen Ltd
- 1D
- -1.36%
- 1M
- -19.44%
- YTD
- -77.73%
- 6M
- -72.38%
- 1Y
- -5.23%
- 3Y*
- -55.21%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.68%
- YTD
- 11.16%
- 6M
- 11.10%
- 1Y
- 27.46%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
PEPG Monthly Returns History
Based on dividend-adjusted daily data since May 6, 2022, PEPG's average daily return is +0.14%, while the average monthly return is +4.61%. At this rate, an investment would double in approximately 1.3 years.
Historically, 38% of months were positive and 62% were negative. The best month was Sep 2025 with a return of +298.3%, while the worst month was Mar 2026 at -71.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, PEPG closed higher 46% of trading days. The best single day was Sep 25, 2025 with a return of +121.1%, while the worst single day was Mar 31, 2026 at -58.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -21.20% | 21.25% | -71.54% | -7.34% | -8.54% | -3.33% | -77.73% | ||||||
| 2025 | -65.96% | 144.19% | -55.40% | 11.74% | -7.01% | -23.97% | 23.42% | -15.33% | 298.28% | 0.87% | 38.20% | 1.09% | 71.77% |
| 2024 | 47.50% | 68.99% | -13.27% | -16.46% | 32.98% | -2.27% | -28.38% | -15.75% | -11.21% | -22.57% | -23.72% | -24.95% | -44.26% |
| 2023 | 16.83% | -2.24% | -19.91% | 23.39% | -0.73% | -40.32% | -33.00% | 5.18% | -19.37% | 0.79% | -4.30% | 38.78% | -49.14% |
| 2022 | -13.19% | -11.26% | 12.79% | -15.18% | -4.42% | 35.24% | 21.82% | -10.63% | 3.72% |
Benchmark Metrics
PepGen Ltd has an annualized alpha of 19.66%, beta of 1.05, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since May 09, 2022.
- This stock participated in 220.51% of S&P 500 Index downside but only 1.02% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 19.66%
- Beta
- 1.05
- R²
- 0.02
- Upside Capture
- 1.02%
- Downside Capture
- 220.51%
Return for Risk
Risk / Return Rank
PEPG ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for PepGen Ltd (PEPG) and compare them to S&P 500 Index.
| PEPG | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.00 | 2.39 | -2.38 |
Sortino ratioReturn per unit of downside risk | 1.41 | 3.25 | -1.84 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.43 | -0.23 |
Calmar ratioReturn relative to maximum drawdown | 0.01 | 3.11 | -3.10 |
Martin ratioReturn relative to average drawdown | 0.02 | 14.38 | -14.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the PepGen Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the PepGen Ltd was 94.61%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current PepGen Ltd drawdown is 92.18%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -94.61%Apr 2025 | 8mo 13d | — | 1y 10moJul 2024 - now |
2023 bear market2023 | -78.19%Nov 2023 | 7mo 25d | 6mo 28d | 1y 2moMar 2023 - Jun 2024 |
Bear market2022 | -62.30%Sep 2022 | 4mo 15d | 20d | 5mo 5dMay 2022 - Oct 2022 |
Bear market2022 | -35.89%Oct 2022 | 9d | 26d | 1mo 5dOct 2022 - Nov 2022 |
2023 bear market2023 | -22.43%Mar 2023 | 27d | 4d | 1mo 1dFeb 2023 - Mar 2023 |
Drawdown Indicators
| PEPG | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.61% | -56.78% | -37.83% |
Max Drawdown (1Y)Largest decline over 1 year | -80.75% | -9.10% | -71.65% |
Max Drawdown (3Y)Largest decline over 3 years | -94.61% | -18.90% | -75.71% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -92.18% | 0.00% | -92.18% |
Average DrawdownAverage peak-to-trough decline | -52.12% | -10.72% | -41.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.26% | 1.97% | +34.29% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of PepGen Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how PepGen Ltd is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PEPG in comparison with other companies in the Biotechnology industry. Currently, PEPG has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PEPG
Add PepGen Ltd to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PEPG